Vaccines safe for long-term care residents, first-month data show
By
Alicia Lasek
Feb 23, 2021
Resident deaths following receipt of a COVID-19 vaccination are not linked to the shot, according to data reported to the Centers for Disease Control and Prevention.
CDC posts videos to educate staff, residents on its 2 vaccine safety systems
By
Alicia Lasek
Mar 17, 2021
YouTube videos detail the VAERS reporting system for CNAs and other facility providers, plus the agency’s smartphone-enabled post-vaccination health checker, or v-safe, which can be used by residents...
HHS to LTC operators: Step up your booster clinic timelines before year ends
By
Alicia Lasek
Dec 22, 2021
Long-term care operators should speed up plans to help residents boost their immunity before an expected COVID-19 surge hits, a federal official told virtual town hall attendees Tuesday.
LeadingAge releases booster shot toolkit for senior living, home care settings
By
Alicia Lasek
Oct 06, 2021
The kit provides links to sources of support for on-site booster clinic set-up and guidance for administrators who must encourage off-site vaccine access.
Makers of newer vaccines tout advantages as trial results and approvals announced
By
Alicia Lasek
Feb 01, 2021
Two drugmakers say their vaccines, which include J&J’s one-dose candidate, are effective against new coronavirus variants, while AstraZeneca’s vaccine is now approved for adults across the...
New CDC data: Vaccinated older adults have low chance of COVID hospitalization
By
Alicia Lasek
Aug 09, 2021
The three FDA-authorized COVID-19 vaccines are highly effective in keeping the oldest adults out of the hospital, according to federal data released Friday.
Retail giants wrap up vaccine clinics, launch new LTC services for ongoing care
By
Alicia Lasek
Apr 23, 2021
CVS Health and Walgreens have completed their final LTC clinics, and are handing the reins to Omnicare and PharMerica to provide ongoing COVID-19 vaccination services in skilled nursing facilities and...
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
No unexpected pattern of adverse booster shot reactions reported by CDC app users
By
Alicia Lasek
Sep 30, 2021
Most v-safe app respondents reported mild to moderate, transient reactions, usually the day after vaccination, CDC investigators say. Sixty percent of respondents were between the ages of 50 and 74.
J&J vaccine effective against COVID Delta variant, drugmaker says
By
Alicia Lasek
Jul 06, 2021
Johnson & Johnson’s single-shot COVID-19 vaccine prompts a “strong neutralizing antibody response” that lasts at least eight months, the drugmaker has announced.